Altos Labs, based in San Francisco, was founded in 2021 by Hans Bishop and Richard Klausner. Hal Barron is the company’s CEO. The biotech company is focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease, injuries, and disabilities that can occur through life.

Scientists say that this rejuvenation process holds great potential to treat vision loss, spinal cord injuries, brain injuries and other age-related bodily degeneration. In a 2018 study, Salk Institute biochemist Juan Carlos Izpisua Belmonte declared this process "the elixir of life" and said that "aging is not an irreversible process."

Among the leading investors are Amazon founder Jeff Bezos and ARCH Venture Partners, along with other wealthy individuals from Silicon Valley and the Persian Gulf. Remarkably, the company has raised $3 billion in funding. The company, which has a last known valuation of $3.67 billion, has not officially endorsed a plan to participate in an IPO.

Register for Details

For more details on financing and valuation for Altos Labs, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Altos Labs's ticker symbol?

Altos Labs does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Altos Labs's stock price?

The stock price for Altos Labs will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Who are Altos Labs's major investors?

Arch Venture Partners
Foresite Capital
Mubadala Investment Company

Altos Labs Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
3/25/2022 Series B $819.55MM raised $XXX.XX $XXX.XX
9/4/2021 Series A $336.39MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Altos Labs

Forge green plus iconForge green minus icon

What is Altos Labs funding to date?

Altos Labs has raised $1.16B to date.
Forge green plus iconForge green minus icon

When was Altos Labs founded?

Altos Labs was founded in 2021.
Forge green plus iconForge green minus icon

Can you invest in Altos Labs?

Altos Labs is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Altos Labs share pre-IPO?

If you own Altos Labs pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Altos Labs a publicly traded company?

Altos Labs is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

Did Jeff Bezos invest in Altos Labs?

Jeff Bezos invested in Altos Labs in 2022.

Forge green plus iconForge green minus icon

What does Altos Labs do?

Altos Labs is a new biotechnology company focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease to transform medicine.

Forge green plus iconForge green minus icon

Who is the CEO of Altos Labs?

The CEO of Altos Labs is Hal Barron.

Other companies like Altos Labs in the Healthcare sector

Sector
Last Round Est. Valuation
$3.45B
Sector
Last Round Est. Valuation
$656.14MM
Sector
Last Round Est. Valuation
$705.25MM
Sector
Last Round Est. Valuation
$1.15B
Sector
Last Round Est. Valuation
$1.22B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$3.66B
Updated on: Dec 21, 2022